Jakafi

Blood cancer trial finds ruxolitinib better than current treatments
Clinical Trials Arena
Fri, 05/5/23 - 10:13 am
clinical trials
polycythemia vera
Jakafi
Incyte
Incyte Abandons Phase III Trial for Myelofibrosis Treatment
BioSpace
Mon, 03/6/23 - 11:06 am
Incyte
clinical trials
myelofibrosis
Jakafi
Incyte on a Roll with Two FDA Wins in Two Days
BioSpace
Thu, 09/23/21 - 10:55 pm
Incyte
FDA
Jakafi
graft vs host disease
ruxolitinib
atopic dermatitis
Incyte to pay $12.6 million to resolve drug charity kickback claims
Reuters
Fri, 05/7/21 - 10:54 am
Incyte
Jakafi
kickbacks
Medicare
Incyte Drug Misses Endpoint in COVID-Respiratory-Distress Trial
TheStreet.com
Sun, 03/21/21 - 11:57 pm
Incyte
Jakafi
clinical trials
COVID-19
ARDS
Jakafi failed the primary endpoint in a Covid-19 study. But Incyte is still going to FDA with a compassionate use pitch
Endpoints
Fri, 03/19/21 - 10:49 am
Jakafi
Incyte
COVID-19
clinical trials
FDA to quickly review Incyte’s Jakafi in chronic GVHD
Pharmaforum
Tue, 02/23/21 - 10:42 am
FDA
Incyte
Jakafi
graft vs host disease
Novartis/Incyte draw blank with Jakafi in COVID-19
Pharmaforum
Mon, 12/14/20 - 10:35 am
Novartis
Incyte
Jakafi
COVID-19
clinical trials
Novartis, Incyte's Jakafi boosts its case in graft-versus-host disease with another phase 3 win
Fierce Pharma
Wed, 04/22/20 - 10:45 pm
Novartis
Incyte
Jakafi
clinical trials
COVID-19
cytokine storm
graft vs host disease
Incyte, Novartis launch drug study to treat coronavirus complication
Marketwatch
Sat, 04/18/20 - 11:22 pm
Incyte
Novartis
cytokine storm
COVID-19
clinical trials
Jakafi
Incyte to Test Its Cancer Drug Jakafi as a Treatment for COVID-19
Motley Fool
Fri, 04/3/20 - 12:02 am
cancer
COVID-19
Incyte
Jakafi
Can Jakafi hit $3B? Incyte thinks so—and it's got other launches on the way
Fierce Pharma
Thu, 02/13/20 - 11:28 pm
Incyte
Jakafi
pemigatinib
Is IBD 50 Drugmaker Incyte Stock On The Cusp Of Innovation-Fueled Growth Spurt?
Investors Business Daily
Tue, 12/3/19 - 09:47 am
Incyte
Jakafi
innovation
Incyte's cash cow Jakafi chugs along with positive frontline results for GVHD
Endpoints
Wed, 10/16/19 - 12:23 pm
Incyte
FDA
graft vs host disease
Jakafi
This Could Be a Big Year for Incyte
Motley Fool
Wed, 09/18/19 - 06:52 pm
Incyte
Jakafi
blood cancers
Incyte (INCY) Receives FDA Nod for Label Expansion of Jakafi
Yahoo/Zacks.com
Tue, 05/28/19 - 10:07 am
FDA
Incyte
Jakafi
graft vs host disease
Incyte Down as FDA Extends Review Period of Jakafi for GVHD
Yahoo/Zacks.com
Sat, 02/9/19 - 12:23 pm
Incyte
FDA
Jakafi
graft vs host disease
FDA Grants Priority Review for Ruxolitinib (Jakafi) for Acute Graft-Versus-Host Disease
CP Wire
Thu, 10/25/18 - 09:52 am
FDA
Incyte
Novartis
Jakavi
Jakafi
graft vs host disease
FDA Grants Priority Review for Ruxolitinib (Jakafi) for Acute Graft-Versus-Host Disease
Thu, 10/25/18 - 09:35 am
Incyte
graft vs host disease
Novartis
Jakafi
Incyte preps Jakafi expansion into graft-versus-host disease
Biopharma Dive
Thu, 06/21/18 - 11:00 pm
Incyte
Jakafi
graft vs host disease

Pages